Toronto Presents at IHPBA 2018

Toronto Fellows and Faculty will join international colleagues at the IHPBA Conference in Geneva next week. Participants this year include Toronto HPB/Transplant Fellows Graziano Oldani, and Blayne A. Sayed as well as Fellowship Research Director, Gonzalo Sapisochin. Details are available at the following links:   Dr. Graziano Oldani – Tuesday September 4th, 2018  – Clinical Case and Discussion https://www.ihpba2018.com/post-graduate-course.html Post Graduate Course – Classification/Guideline Driven Management in HPB This course, driven by international classifications and guidelines, focuses on the management of common HPB diseases. Each topic will be presented in a structured way, detailing the rationale of treatment at various stages of the disease, and highlighting modern and new aspects. It is ideal for more junior colleagues (i.e. those still in training and younger surgeons), wishing to broaden their field of knowledge and improve daily practice. Session 4: Bile Duct 2 Moderators: Albert Chan (Hong Kong); Christian Toso (Switzerland)   Free Papers (Mini Oral) – Transplant: LDT/Basic Science – Friday September 7th, 2018 Chairs: Derek Manas (United Kingdom); Mickaël Lesurtel (France) FP26-06 – “Graft Remodelling after Transplantation of Chimeric Mouse/Rat Livers into Rats” Presenting Author: Graziano Oldani (Switzerland)   Dr. Blayne A. Sayed – HPB General  – Electronic Poster Tricks of the Trade – E-Posters are available to view throughout the congress open hours at designated workstations located in the Exhibition Hall 3 E-poster: A Technique for Decreasing Delayed Gastric Emptying in the Setting of Pancreatic Fistula Presenting Author: Blayne Amir Sayed (Canada)   Dr. Gonzalo Sapisochin – Wednesday September 5th, 2018 https://www.ihpba2018.com/meet-the-professor.html Meet the Professor – Meet the Professor breakfast sessions allow delegates to meet in a small group...

Toronto Faculty Co-chairs Practice Changing International Study

Unicancer GI PRODIGE 24/CCTG PA.6 trial’,  is a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas. Dr. Alice Wei, Associate Professor of Surgery & Institute of Health Policy, Management and Evaluation at the University of Toronto, is the Canadian Co-chair for the trial and the Pancreas Research group at UHN’s Princess Margaret Cancer Centre accrued many of the Canadians for this cooperative group study between Unicancer and the Canadian Cancer Trials Group. Presented at the ASCO meeting in Chicago this summer, the study concluded that adjuvant mFOLFIRINOX is safe and significantly improves DFS, MFS and OS compared to gem. The abstract is available at the following link:...

Toronto HPB Surgical Oncology Fellowship Reaccredited

The Fellowship Council Board of Directors has once again accredited the HPB Surgical Oncology Program at the Toronto General Hospital. The program’s 2 year Fellowship subscribes to the standards set by the AHPBA and participates in the North American match of the Fellowship Council. Additional information on the Fellowship Council Match available...